280 related articles for article (PubMed ID: 9576007)
21. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
[TBL] [Abstract][Full Text] [Related]
22. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
Benihoud K; Bonardelle D; Bobé P; Kiger N
Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
[TBL] [Abstract][Full Text] [Related]
23. Terminal deoxynucleotidyl transferase deficiency decreases autoimmune disease in MRL-Fas(lpr) mice.
Feeney AJ; Lawson BR; Kono DH; Theofilopoulos AN
J Immunol; 2001 Sep; 167(6):3486-93. PubMed ID: 11544342
[TBL] [Abstract][Full Text] [Related]
24. Lymphocytes from autoimmune MRL lpr/lpr mice are hyperresponsive to IL-18 and overexpress the IL-18 receptor accessory chain.
Neumann D; Del Giudice E; Ciaramella A; Boraschi D; Bossù P
J Immunol; 2001 Mar; 166(6):3757-62. PubMed ID: 11238617
[TBL] [Abstract][Full Text] [Related]
25. MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells.
Mandik-Nayak L; Seo SJ; Sokol C; Potts KM; Bui A; Erikson J
J Exp Med; 1999 Jun; 189(11):1799-814. PubMed ID: 10359584
[TBL] [Abstract][Full Text] [Related]
26. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
Chan OT; Madaio MP; Shlomchik MJ
J Immunol; 1999 Oct; 163(7):3592-6. PubMed ID: 10490951
[TBL] [Abstract][Full Text] [Related]
27. Hypogammaglobulinaemia occurs in Fas-deficient MRL-lpr mice following deletion of MHC class II molecules.
Anderson CC; Mukherjee R; Sinclair NR; Jevnikar AM
Clin Exp Immunol; 1997 Sep; 109(3):473-9. PubMed ID: 9328125
[TBL] [Abstract][Full Text] [Related]
28. In CD8+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes.
Giese T; Davidson WF
J Immunol; 1995 May; 154(10):4986-95. PubMed ID: 7537297
[TBL] [Abstract][Full Text] [Related]
29. Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice.
Tada Y; Nagasawa K; Ho A; Morito F; Koarada S; Ushiyama O; Suzuki N; Ohta A; Mak TW
J Immunol; 1999 Sep; 163(6):3153-9. PubMed ID: 10477582
[TBL] [Abstract][Full Text] [Related]
30. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
[TBL] [Abstract][Full Text] [Related]
31. Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus.
Shimp SK; Chafin CB; Regna NL; Hammond SE; Read MA; Caudell DL; Rylander M; Reilly CM
Cell Mol Immunol; 2012 May; 9(3):255-66. PubMed ID: 22543833
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL/lpr Mice.
Rohraff DM; He Y; Farkash EA; Schonfeld M; Tsou PS; Sawalha AH
Arthritis Rheumatol; 2019 Oct; 71(10):1681-1690. PubMed ID: 31106974
[TBL] [Abstract][Full Text] [Related]
33. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ
J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978
[TBL] [Abstract][Full Text] [Related]
34. Absence of CD59 exacerbates systemic autoimmunity in MRL/lpr mice.
Miwa T; Zhou L; Maldonado MA; Madaio MP; Eisenberg RA; Song WC
J Immunol; 2012 Dec; 189(11):5434-41. PubMed ID: 23109726
[TBL] [Abstract][Full Text] [Related]
35. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
Kikawada E; Lenda DM; Kelley VR
J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
[TBL] [Abstract][Full Text] [Related]
36. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.
Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC
J Immunol; 1998 Nov; 161(10):5164-70. PubMed ID: 9820486
[TBL] [Abstract][Full Text] [Related]
37. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
[TBL] [Abstract][Full Text] [Related]
38. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
[TBL] [Abstract][Full Text] [Related]
39. EGR2 is elevated and positively regulates inflammatory IFNγ production in lupus CD4
Dai R; Heid B; Xu X; Xie H; Reilly CM; Ahmed SA
BMC Immunol; 2020 Jul; 21(1):41. PubMed ID: 32646370
[TBL] [Abstract][Full Text] [Related]
40. Regulation of T cell-dependent autoantibody production by a gammadelta T cell line derived from lupus-prone mice.
Fujii T; Okada M; Craft J
Cell Immunol; 2002; 217(1-2):23-35. PubMed ID: 12425998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]